Executives Leave Cassava, Maker of Controversial Alzheimer's Drug

The CEO and a chief scientist resigned just weeks after a federal grand jury brought fraud charges against a research collaborator.

Leave a Reply

Your email address will not be published. Required fields are marked *

romabet güncel giriş betgar güncel giriş